Articles

Selection of published articles on Radiopharmacy

If you know someone else that is interesting, please write a comment at the bottom of the page.

If you make a mess with your bibliography you have gathered, there is available a free program for its management, called Biblioseeker, that will help you find the items you are interested and can make the search depending on the year, file title, authors or keywords. It gives you a little of work at first, because you have to enter yourself your bibliography data, but once you get used to it is very useful.

*******************************************************************

A simple method for checking the proper functioning of a thin-layer radiochromatograph for radiochemical purity control of radiopharmaceuticals

Appl Radiat Isot. 2016 Dec;118:102-104

______________________________________________________

Effect of blood activity on dosimetric calculations for radiopharmaceuticals

Phys Med Biol. 2016 Nov 7;61(21):7688-7703

______________________________________________________

68 Ga-Ca-phytate particles: A potential lung perfusion agent of synthetic origin prepared in a cold kit format

J Labelled Comp Radiopharm. 2016 Oct;59(12):506-516

______________________________________________________

The concept of minimum detectable activity of radionuclide activity meters and their suitability for routine quality control of radiopharmaceuticals. An experimental study

Appl Radiat Isot. 2016 Jul;113:22-7

______________________________________________________

Fractionated elution using the TEKCIS technetium-99m generator

Nucl Med Commun. 2016 Jun;37(6):664-8

______________________________________________________

Detailed evaluation of different (68)Ge/(68)Ga generators: an attempt toward achieving efficient (68)Ga radiopharmacy

J Labelled Comp Radiopharm. 2016 Mar;59(3):87-94

______________________________________________________

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals

EJNMMI Radiopharmacy and Chemistry (2016) 1:1. Published: 21 March 2016

______________________________________________________

Small Molecule Radiopharmaceuticals – A Review of Current Approaches

Front Med (Lausanne). 2016 Feb 23;3:5. doi: 10.3389/fmed.2016.00005. eCollection 2016.

______________________________________________________

Evaluation of a Labelled Bacteriophage with 99mTc as a Potential Agent for Infection Diagnosis

Curr Radiopharm. 2016 Feb 15. [Epub ahead of print]

______________________________________________________

Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia

Nucl Med Biol. 2016 Feb;43(2):165-70

______________________________________________________

Residual activities of 99mTc-labelled radiopharmaceuticals in routine nuclear medicine practice

Nucl Med Commun. 2016 Feb 2. [Epub ahead of print]

______________________________________________________

Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153

Appl Radiat Isot. 2016 Apr;110:87-99.

______________________________________________________

Evaluation of the Efficacy of Targeted Imaging Agents

J Nucl Med. 2016 Jan 14. pii: jnumed.115.169235. [Epub ahead of print]

______________________________________________________

Aptamers as radiopharmaceuticals for nuclear imaging and therapy

Nucl Med Biol. 2015 Sep 28. pii: S0969-8051(15)00164-X. doi: 10.1016/j.nucmedbio.2015.09.005. [Epub ahead of print]

______________________________________________________

Improving efficiency management of radiopharmaceutical materials at a nuclear medicine department

BMJ Qual Improv Rep. 2015 Sep 2;4(1).

______________________________________________________

Preparation, characterization and evaluation of (186) Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma

J Labelled Comp Radiopharm. 2016 Feb;59(2):72-7.

______________________________________________________

Study of the radiation effect of 99Mo/99mTc generator on Bacillus subtilis and Bacillus pumilus species.

Appl Radiat Isot. 2016 Jan;107:33-9

______________________________________________________

Advances in Peptide Receptor Radionuclide Therapy

Semin Nucl Med. 2016 Jan;46(1):40-6

______________________________________________________

Molybdenum target specifications for cyclotron production of (99m)Tc based on patient dose estimates

Phys Med Biol. 2016 Jan 21;61(2):542-53

______________________________________________________

European rules to bring novel radiopharmaceuticals to the clinic

Q J Nucl Med Mol Imaging. 2017 Jan 26

______________________________________________________

Adjusting ACR Appropriateness Criteria for Novel Radiopharmaceuticals

J Am Coll Radiol. 2015 Dec;12(12 Pt A):1242-3. doi: 10.1016/j.jacr.2015.08.021.

______________________________________________________

68 Ga-labeled Ciprofloxacin Conjugates as Radiotracers for Targeting Bacterial Infection

Chem Biol Drug Des. 2015 Dec 9

______________________________________________________

Preparation, biodistribution and scintigraphic evaluation of (99m)Tc-lincomycin

Pak J Pharm Sci. 2015 Nov;28(6):1965-70.

______________________________________________________

Cyclotron production of (43)Sc for PET imaging

EJNMMI Phys. 2015 Dec;2(1):33

______________________________________________________

The strange case of the [13N]NH3: validation of the production process for human use

Nucl Med Commun. 2016 Apr;37(4):412-21.

______________________________________________________

Radionuclidic purity tests in 18F radiopharmaceutIcals production process

Appl Radiat Isot. 2015 Nov 5.

______________________________________________________

Radiolabeled Peptides for Imaging and Therapy: A Radiant Future

J Nucl Med. 2015 Oct 29

______________________________________________________

Studies on batch formulation of a kit for the preparation of the 99mTc-Ubiquicidin (29-41): An infection imaging agent

Appl Radiat Isot. 2015 Sep 11;107:8-12.

______________________________________________________

Radiopharmacology: recent developments in the field of radiopharmaceuticals

Q J Nucl Med Mol Imaging. 2015 Sep;59(3):239-40.

______________________________________________________

Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals

Semin Nucl Med. 2015 Sep;45(5):470-8

______________________________________________________

68Ga-Based Radiopharmaceuticals: Production and Application Relationship

Molecules. 2015 Jul 16;20(7):12913-43

______________________________________________________

(99m) Tc-human serum albumin nanocolloids: particle sizing and radioactivity distribution

J Labelled Comp Radiopharm. 2015 Jul;58(9):376-82

______________________________________________________

Freeware for reporting radiation dosimetry following the administration of radiopharmaceuticals

Appl Radiat Isot. 2015 Sep;103:131-4

______________________________________________________

Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances

Ann ICRP. 2015 Jul;44(2 Suppl):7-321

______________________________________________________

Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results

J Labelled Comp Radiopharm. 2015 May 30;58(6):242-9

______________________________________________________

Recent progress of imaging agents for Parkinson’s disease

Curr Neuropharmacol. 2014 Dec;12(6):551-63

______________________________________________________

GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use

EJNMMI Res. 2015 Apr 24;5:27

______________________________________________________

Retention of [(18)F]fluoride on reversed phase HPLC columns

J Pharm Biomed Anal. 2015 Jul 10;111:209-14

______________________________________________________

Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications

Chem Rev. 2015 Apr 22;115(8):2934-74

______________________________________________________

Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors

J Med Chem. 2015 May 14;58(9):3817-29

______________________________________________________

Drug Delivery Systems for Imaging and Therapy of Parkinson’s Disease

Curr Neuropharmacol. 2016 May; 14(4): 376–391.

______________________________________________________

Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals

Inorg Chem. 2015 Apr 6;54(7):3462-8

______________________________________________________

Single vial kit formulation of DOTATATE for preparation of (177) Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy

J Labelled Comp Radiopharm. 2015 Apr;58(4):166-72

______________________________________________________

Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with (177)Lu and Conjugated to Peptides

Curr Radiopharm. 2015;8(2):150-9.

______________________________________________________

Chemistry and bifunctional chelating agents for binding (177)Lu

Curr Radiopharm. 2015;8(2):86-94.

______________________________________________________

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [99mTc(MIBI)6]+

Braz J Med Biol Res. 2015 Mar 3;0:0.

______________________________________________________

Development of a simple kit-based method for preparation of pharmaceutical-grade ⁶⁸Ga-DOTATOC

Nucl Med Commun. 2015 May;36(5):502-10

______________________________________________________

Blood volume analysis by radioisotopic dilution techniques: State of the art

Appl Radiat Isot. 2015 Feb;96C:71-82. doi: 10.1016/j.apradiso.2014.11.014. Epub 2014 Nov 20.

_______________________________________________________

SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade

Q J Nucl Med Mol Imaging. 2015 Feb 11. [Epub ahead of print]

_______________________________________________________

Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach

Nucl Med Commun. 2015 Feb 2. [Epub ahead of print]

_______________________________________________________

Radiopharmaceuticals as probes to characterize tumour tissue

Eur J Nucl Med Mol Imaging. 2015 Feb 3. [Epub ahead of print]

_______________________________________________________

Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database

Ann Pharmacother. 2015 Jan;49(1):39-47. doi: 10.1177/1060028014558153. Epub 2014 Nov 3.
_______________________________________________________

Altered Biodistribution of Radiopharmaceuticals Used in Bone Scintigraphy

Semin Nucl Med. 2015 Jan;45(1):81-96. doi: 10.1053/j.semnuclmed.2014.07.007.

_______________________________________________________

Assessment of technetium-99m succimer residual activity reduction using inert non-reactive syringes

J Nucl Med Technol. 2014 Dec 23. pii: jnmt.114.147983. [Epub ahead of print]

_______________________________________________________

Clinical application of ultrasound for preparation of 99mTc-sestamibi complex

Ann Nucl Med. 2014 Dec 25. [Epub ahead of print]

_______________________________________________________

Radiopharmaceuticals in nuclear medicine: recent developments for SPECT and PET studies

Biomed Res Int. 2014;2014:426892. doi: 10.1155/2014/426892. Epub 2014 Dec 21.

_______________________________________________________

Diversification of 99Mo/99mTc separation: Non-fission reactor production of 99Mo as a strategy for enhancing 99mTc availability

J Nucl Med. 2014 Dec 23. pii: jnumed.114.149609. [Epub ahead of print]

_______________________________________________________

Theranostic nanoparticles

J Nucl Med. 2014 Dec;55(12):1919-22. doi: 10.2967/jnumed.114.146019. Epub 2014 Nov 20.

_______________________________________________________

Radiolabeling in Biology

Cell Biochem Biophys. 2014 Nov 21. [Epub ahead of print]

_______________________________________________________

Radiation dose concerns for the pregnant or lactating patient

Semin Nucl Med. 2014;44(6):479-88. doi: 10.1053/j.semnuclmed.2014.06.003.

_______________________________________________________

Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine

Pediatr Radiol. 2014 Nov 1. [Epub ahead of print]

_______________________________________________________

A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion

PLoS One. 2014 Oct 29;9(10):e109361. doi: 10.1371/journal.pone.0109361. eCollection 2014.

_______________________________________________________

Radioactivity decontamination of materials commonly used as surfaces in general-purpose radioisotope laboratories

J Nucl Med Technol. 2014 Dec;42(4):292-5. doi: 10.2967/jnmt.114.144303. Epub 2014 Oct 23.

_______________________________________________________

Absorbed radiation doses to staff after implementation of a radiopharmacy clean room

J Nucl Med Technol. 2014 Dec;42(4):289-91. doi: 10.2967/jnmt.114.143289. Epub 2014 Aug 28.

_______________________________________________________

Particle-Size and Radiochemical Purity Evaluations of Filtered 99mTc-Sulfur Colloid Prepared with Different Heating Times

J Nucl Med Technol. 2014 Dec;42(4):283-8. doi: 10.2967/jnmt.114.145391. Epub 2014 Aug 7.

_______________________________________________________

Samarium-153 EDTMP for metastatic bone pain palliation: The impact of europium impurities

Phys Med. 2014 Nov 13. pii: S1120-1797(14)00622-X. doi: 10.1016/j.ejmp.2014.10.078. [Epub ahead of print]

_______________________________________________________

Limulus Amebocyte Lysate Testing: Adapting It for Determination of Bacterial Endotoxin in 99mTc-Labeled Radiopharmaceuticals at a Hospital Radiopharmacy

J Nucl Med Technol. 2014 Dec;42(4):278-82. doi: 10.2967/jnmt.114.146779. Epub 2014 Nov 13.

_______________________________________________________

Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes

Bioconjug Chem. 2014 Dec 4. [Epub ahead of print]

_______________________________________________________

Altered Biodistribution of Radiopharmaceuticals Used in Bone Scintigraphy

Semin Nucl Med. 2015 Jan;45(1):81-96. doi: 10.1053/j.semnuclmed.2014.07.007.

_______________________________________________________

Adverse Reactions to Radiopharmaceuticals in France: Analysis of the National Pharmacovigilance Database

Ann Pharmacother. 2014 Nov 3. pii: 1060028014558153

_______________________________________________________

Preparation and radiochemical control of 99mTc labeled blood pool agent for in vivo labelling of the red blood cells

Acta Pol Pharm. 2014 Mar-Apr;71(2):245-8

_______________________________________________________

Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals

Nucl Med Biol. 2014 Aug 23. pii: S0969-8051(14)00487-9. doi: 10.1016/j.nucmedbio.2014.08.012

_______________________________________________________

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2175-85. doi: 10.1007/s00259-014-2866-8.

_______________________________________________________

In vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticals

Nucl Med Biol. 2014 Oct;41(9):772-4. doi: 10.1016/j.nucmedbio.2014.05.141. Epub 2014 Jun 2

_______________________________________________________

Radiosynthesis and Bioevaluation of [68Ga]-Labeled 5,10,15,20-Tetra(4-methylpyridyl)-porphyrin for Possible Application as a PET Radiotracer for Tumor Imaging.

Mol Imaging Biol. 2014 Jul 19. [Epub ahead of print]

_______________________________________________________

Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2005-7. doi: 10.1007/s00259-014-2838-z.

_______________________________________________________

99mTc-labeled vasopressin peptide as a radiopharmaceutical for small-cell lung cancer (SCLC) diagnosis

J Med Chem. 2014 Jul 24;57(14):5986-94. doi: 10.1021/jm500272r. Epub 2014 Jul 8.

_______________________________________________________

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence

Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014

_______________________________________________________

Radiopharmaceutical stem cell tracking for neurological diseases

Biomed Res Int. 2014;2014:417091. doi: 10.1155/2014/417091. Epub 2014 May 25

_______________________________________________________

Development of 68Ga-labeled fatty acids for their potential use in cardiac metabolic imaging

J Labelled Comp Radiopharm. 2014 Jun 15;57(7):463-9. doi: 10.1002/jlcr.3205

_______________________________________________________

Nuclear imaging to support anti-inflammatory drug discovery and development

Q J Nucl Med Mol Imaging. 2014 May 15. [Epub ahead of print]

_______________________________________________________________

Targeting monocytes and macrophages by means of spect and pet

Q J Nucl Med Mol Imaging. 2014 May 21. [Epub ahead of print]

_______________________________________________________________

Evaluation of body surface area formulae for scaling GFR of adult renal patients: More between-subjects variability explained by DuBois&DuBois formula

Q J Nucl Med Mol Imaging. 2014 Jun 10. [Epub ahead of print]

_______________________________________________________________

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease

Biomed Res Int. 2014;2014:942960. Epub 2014 May 11.

_______________________________________________________________

Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications

J Labelled Comp Radiopharm. 2014 May 29. doi: 10.1002/jlcr.3203.

_______________________________________________________________

Performance of a 62Zn/62Cu microgenerator in kit-based synthesis and delivery of [62Cu]Cu-ETS for PET perfusion imaging

Appl Radiat Isot. 2014 May 22;91C:38-43. doi: 10.1016/j.apradiso.2014.05.006.

_______________________________________________________________

Synthesis and preliminary evaluation of novel 99mTc-labeled folate derivative via click reaction for SPECT imaging

Appl Radiat Isot. 2014 May 14;91C:24-30. doi: 10.1016/j.apradiso.2014.04.020

_______________________________________________________________

Prevalence of Adverse Events to Radiopharmaceuticals from 2007 to 2011

J Nucl Med. 2014 May 29. pii: jnumed.114.138057

_______________________________________________________________

A (99m) Tc(CO)3 -labeled benzylguanidine with persistent heart uptake

J Labelled Comp Radiopharm. 2014 May 15;57(5):358-64. doi: 10.1002/jlcr.3188

_______________________________________________________________

Alpha-emitter radium-223 in the management of solid tumors: current status and future directions

Am Soc Clin Oncol Educ Book. 2014;34:e132-9. doi: 10.14694/EdBook_AM.2014.34.e132.

_______________________________________________________________

The role of preclinical models in radiopharmaceutical therapy

Am Soc Clin Oncol Educ Book. 2014;34:e121-5. doi: 10.14694/EdBook_AM.2014.34.e121.

_______________________________________________________________

New rhenium complexes with ciprofloxacin as useful models for understanding the properties of [(99m)Tc]-ciprofloxacin radiopharmaceutical

Bioorg Med Chem. 2014 Jul 1;22(13):3262-9. doi: 10.1016/j.bmc.2014.04.058.

_______________________________________________________________

Targeting monocytes and macrophages by means of spect and pet

Q J Nucl Med Mol Imaging. 2014 May 21

_______________________________________________________________

Pediatric Nuclear Medicine and Radiation Dose

Semin Nucl Med. 2014 May;44(3):202-209. doi: 10.1053/j.semnuclmed.2014.03.009.

_______________________________________________________________

Dosimetry for Radiopharmaceutical Therapy

Semin Nucl Med. 2014 May;44(3):172-178. doi: 10.1053/j.semnuclmed.2014.03.007.

_______________________________________________________________

Possibilities of optical imaging of the (99m)Tc-based radiopharmaceuticals

J Biomed Opt. 2014 Apr;19(4):046014. doi: 10.1117/1.JBO.19.4.046014.

_______________________________________________________________

Production of iodine-124 and its applications in nuclear medicine

Appl Radiat Isot. 2014 Apr 4;90C:138-148. doi: 10.1016/j.apradiso.2014.03.026

_______________________________________________________________

International Guidelines for Pediatric Radiopharmaceutical Administered Activities

J Nucl Med. 2014 Apr 17;55(6):869-870

_______________________________________________________________

Implementation of Multi-Curie Production of 99mTc by Conventional Medical Cyclotrons

J Nucl Med. 2014 Apr 10;55(6):1017-1022.

_______________________________________________________________

PET tracers in musculoskeletal disease beyond FDG

Semin Musculoskelet Radiol. 2014 Apr;18(2):123-32. doi: 10.1055/s-0034-1371015.

_______________________________________________________________

Preparation and evaluation of three mucoadhesive dosage forms using (99m)Tc-Ofloxacin

Appl Radiat Isot. 2014 Jul;89:192-8. doi: 10.1016/j.apradiso.2014.01.031.

_______________________________________________________________

In vitro evaluation of tc-99m radiopharmaceuticals for gastric emptying studies

Mol Imaging Radionucl Ther. 2014 Feb;23(1):21-4. doi: 10.4274/Mirt.75047.

_______________________________________________________________

Evaluation of the bubble point test of a 0.22-μm membrane filter used for the sterilizing filtration of PET radiopharmaceuticals

Ann Nucl Med. 2014 Mar 8.

_______________________________________________________________

Rational development of radiopharmaceuticals for HIV-1

Nucl Med Biol. 2014 Apr;41(4):299-308. doi: 10.1016/j.nucmedbio.2014.01.005.

_______________________________________________________________

Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications

J Nucl Med. 2014 May;55(5):786-98. doi: 10.2967/jnumed.113.133454. Epub 2014 Mar 3.

_______________________________________________________________

Radionuclides in nephrourology, part 1: Radiopharmaceuticals, quality control, and quantitative indices

J Nucl Med. 2014 Apr;55(4):608-15. doi: 10.2967/jnumed.113.133447. Epub 2014 Feb 18.

_______________________________________________________________

¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases

J Nucl Med Technol. 2014 Mar;42(1):55-61. doi: 10.2967/jnmt.113.132266. Epub 2014 Feb 6.

_______________________________________________________________

Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals

J Labelled Comp Radiopharm. 2014 Apr;57(4):239-43. doi: 10.1002/jlcr.3146. Epub 2014 Feb 4.

_______________________________________________________________

Evaluation of alternative rapid thin layer chromatography systems for quality control of technetium-99m radiopharmaceuticals

Appl Radiat Isot. 2014 Apr;86:57-62. doi: 10.1016/j.apradiso.2013.12.016. Epub 2014 Jan 8.

_______________________________________________________________

Development of a new software for comprehensive management and traceability of hospital radiopharmacies

Comput Methods Programs Biomed. 2013 Oct;112(1):166-72

_______________________________________________________________

A portable database of adverse reactions and drug interactions with radiopharmaceuticals

J Nucl Med Technol. 2013 Sep;41(3):212-5

_______________________________________________________________

Radioimmunotherapy with 177 Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas

J Nucl Me. 2013 Jul;54(7):1045-52.

_______________________________________________________________

Radio-UHPLC: A tool for rapidly determining the radiochemical purity of technetium-99m radiopharmaceuticals?

Appl Radiat Isot. 2013 Aug;78:72-6

_______________________________________________________________

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

J Nucl Med 2013; 54:1–8

_______________________________________________________________

Efficacy Considerations for U.S. Food and Drug Administration Approval of Diagnostic Radiopharmaceuticals

J Nucl Med 2013; 54:1–6

_______________________________________________________________

PET radiopharmaceuticals for probing enzymes in the brain

Am J Nucl Med Mol Imaging 2013;3(3):194-216

_______________________________________________________________

Radiofluorination using aluminum-fluoride (Al18F)

EJNMMI Res. 2013 May 8;3(1):36

_______________________________________________________________

Bone metastases radiopharmaceuticals: an overview

Curr Radiopharm. 2013 Mar;6(1):41-7

_______________________________________________________________

Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging

J Nucl Med. 2012 Jun;53(6):969-76

_______________________________________________________________

PET Tracers for Clinical Imaging of Breast Cancer

 J Oncol. 2012;2012:710561

_______________________________________________________________

A computer program for calculation of approximate embryo/fetus radiation dose in nuclear medicine applications

Mol Imaging Radionucl Ther. 2012 Apr;21(1):19-22

_______________________________________________________________

New PET radiopharmaceuticals beyond FDG for brain tumor imaging

 Q J Nucl Med Mol Imaging. 2012 Apr;56(2):173-90

_______________________________________________________________

PET with radiolabeled aminoacid

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):151-62

_______________________________________________________________

Adverse events in nuclear medicine – cause for concern?

Eur J Nucl Med Mol Imaging (2012) 39:782–785

_______________________________________________________________

99mTc-albumin can replace 125I-albumin to determine plasma volume repeatedly

Scand J Clin Lab Invest. 2012 Oct;72(6):447-51

_______________________________________________________________

99mTc-labelled human serum albumin cannot replace 125I-labelled human serum albumin to determine plasma volume in patients with liver disease

Clin Physiol Funct Imaging (2012)

_______________________________________________________________

Giving radioiodine. Think about airport security alarms

Rev Esp Med Nucl Imagen Mol. 2012; 31 (3): 148–150

_______________________________________________________________

A Review on Therapeutic Approach of Radiopharmaceutical in Health Care System

International Journal of Pharmaceutical & Biological Archives 2012; 3(3):487-492

_______________________________________________________________

Survey of the Performance of Commercial Dose Calibrators for Measurement of 123I Activity

J Nucl Med Technol. 2011 Dec;39(4):302-6.

_______________________________________________________________

Experiences with citrate rather than heparin as an anticoagulant for 18F-FDG labeling of leukocytes

J Nucl Med Technol. 2011 Dec;39(4):312-6

_______________________________________________________________

Advances in drug design of radiometal-based imaging agents for bone disorders

Int J Mol Imaging. 2011;2011:537687

_______________________________________________________________

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review

Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2269-81

_______________________________________________________________

Pediatric Radiopharmaceutical Doses. New Guidelines

Radiology: Volume 261: Number 2 – November 2011. radiology.rsna.org

_______________________________________________________________

Extravasation of a Therapeutic Dose of 131I-Metaiodobenzylguanidine. Prevention, Dosimetry, and Mitigation

J Nucl Med 2011; 52:1418–1422

_______________________________________________________________

How to Search Write Prepare and Publish Scientific Papers in the Biomedical Journals

AIM, 2011; 19(2): 68-79

_______________________________________________________________

Radiochemical purity testing of 99mTc-labelled radiopharmaceuticals: how much is enough?

Nuclear Medicine Communications 2011, 32:761–763

_______________________________________________________________

Pitfalls With Radiopharmaceuticals

Am J Med Sci 2011; 342(1):50–53

_______________________________________________________________

99mTc-besilesomab (Scintimun) in peripheral osteomyelitis. Comparison with 99mTc-labelled white blood cells

Eur J Nucl Med Mol Imaging (2011) 38:899–910

_______________________________________________________________

Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine

freeJ Nucl Med. 2011 Aug;52(8):1240-51

_______________________________________________________________

Development of a Comprehensive Software Application for Calculations in Nuclear Medicine and Radiopharmacy

J Nucl Med Technol. 2010 Sep;38(3):153-62

_______________________________________________________________

99Mo 99mTc Generator Shortage Free Web based Software

J Nucl Med • Vol. 51 • No. 8 • August 2010

_______________________________________________________________

Altered Biodistribution of Radiopharmaceuticals Role of Radiochemical Pharmaceutical Purity, Physiological, and Pharmacologic Factors

Semin Nucl Med 2010;40:220-241

_______________________________________________________________

Cyclotron production of 99mTc. An approach to the medical isotope crisis

J Nucl Med. 2010 Apr;51(4):13N-6N

_______________________________________________________________

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

Eur J Nucl Med Mol Imaging. 20 March 2010

_______________________________________________________________

Imaging of NETs with PET radiopharmaceuticals

Q J Nucl Med Mol Imaging 2010; 54:16-23

_______________________________________________________________

Radiolabeled regulatory peptides for imaging and therapy

Current Opinion in Endocrinology, Diabetes & Obesity 2010, 17:69–76

_______________________________________________________________

Radiolabeling optimization and reduced staff radiation exposure for high-dose 90Y-ibritumomab tiuxetan (HD-Zevalin)

Nucl Med Biol. 2010 Jan;37(1):85-93. Epub 2009 Oct 12.

_______________________________________________________________

Unconventional Nuclides for Radiopharmaceuticals

Molecular Imaging, Vol 9, No 1 (January/February 2010): pp 1–20

_______________________________________________________________

The options for the future production of the medical isotope 99Mo

Eur J Nucl Med Mol Imaging (2010) 37:1817–1820

_______________________________________________________________

Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicin

Eur J Nucl Med Mol Imaging. 2010 April;37(4):835-41

_______________________________________________________________

Estimated glomerular filtration rate for drug dose adjustment. Cockcroft and Gault or abbreviated MDRD equation

Clin Biochem. 2009 Jan;42(1-2):111-3. Epub 2008 Oct 9

_______________________________________________________________

 

Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction

Brazilian Journal of  Pharmaceutical Sciences vol. 45, n. 4, oct./dec., 2009

_______________________________________________________________

Latest advances in radiopharmacology and radiopharmacy 2009

Q J Nucl Med Imaging 2009;53:357-8

_______________________________________________________________

Undesirable Events With Radiopharmaceuticals

Tohoku J. Exp. Med., 2009, 217, 251-257

_______________________________________________________________

68Ga-PET a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

Contrast Media Mol. Imaging 2008, 3 67–77

_______________________________________________________________

Adverse Reactions to Radiopharmaceuticals (ARRP) Particularly To Technetium Radiopharmaceuticals

FABAD J. Pharm. Sci., 33, 109–117, 2008

_______________________________________________________________

Evaluation of different counting methods for use in radiochemical purity testing procedures for 99mTc-labelled radiopharmaceuticals

Applied Radiation and Isotopes 66 (2008) 556–559

_______________________________________________________________

GMP Three letters with many interpretations. Protection of patients or killing the clinical and research applications of PET?

Eur J Nucl Med Mol Imaging (2008) 35:693–694

_______________________________________________________________

Radiopharmaceutical Drug Interactions

Rev. salud pública. 10 (3):477-487, 2008

_______________________________________________________________

Radiopharmaceuticals drug interactions. A critical review

Anais da Academia Brasileira de Ciências (2008) 80(4): 665-675

_______________________________________________________________

The specific case of radiopharmaceuticals and GMP – activities of the Radiopharmacy Committee

Eur J Nucl Med Mol Imaging (2008) 35:1400–1401

_______________________________________________________________

Blood Volume Analysis. A New Technique and New Clinical Interest Reinvigorate a Classic Study

J Nucl Med Technol 2007; 35:55–63

_______________________________________________________________

Comparison of Red Cell and Whole Blood Volume as Performed Using Both Chromium-51-Tagged Red Cells and Iodine-125-Tagged Albumin and Using I-131-Tagged Albumin and Extrapolated Red Cell Volume

Am J Med Sci. 2007 Jul;334(1):37-40.

_______________________________________________________________

Development and Prospective Evaluation of an Automated Software System for Quality Control of Quantitative 99mTc-MAG3 Renal Studies

J Nucl Med Technol 2007; 35:27–33

_______________________________________________________________

Development of Radioimmunotherapeutic and Diagnostic Antibodies. An Inside-Out View

Nucl Med Biol. 2007 October ; 34(7): 757–778

_______________________________________________________________

Impact Factors in Nuclear Medicine Journals

J Nucl Med 2007; 48:1397–1400

_______________________________________________________________

Techniques used for the determination of blood volume

Am J Med Sci. 2007 Jul;334(1):32-6

_______________________________________________________________

 

Ten Simple Rules for Making Good Oral Presentations

PLoS Computational Biology. April 2007  Volume 3  Issue 4  e77

_______________________________________________________________

The new EANM paediatric dosage card

Eur J Nucl Med Mol Imaging (2007) 34:796–798

_______________________________________________________________

Yttrium-90 Microspheres (TheraSphere and SIR-Spheres) for the Treatment of Unresectable Hepatocellular Carcinoma.

Issues in Emerging Health Technologies Issue 102 • September 2007

_______________________________________________________________

Structural overview of technetium compounds (2000–2004)

Coordination Chemistry Reviews 250 (2006) 561–573

_______________________________________________________________

Labeling of antibiotics for infection diagnosis

Q J Nucl Med Mol Imaging. 2006 Jun;50(2):147-52

_______________________________________________________________

Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging

European Journal of Pharmaceutics and Biopharmaceutics 62 (2006) 26–31

_______________________________________________________________

Hepatitis C Virus Infections From a Contaminated Radiopharmaceutical Used in Myocardial Perfusion Studies

JAMA, October 25, 2006—Vol 296, No. 16

_______________________________________________________________

A brief history of cell labelling

Q J Nucl Med Mol Imaging 2005;49:304-7

_______________________________________________________________

New directions in the coordination chemistry of 99mTc. A reflection on technetium core structures and a strategy for new chelate design

Nuclear Medicine and Biology 32 (2005) 1–20

_______________________________________________________________

Optimised tracer-dependent dosage cards to obtain weight-independent effective doses

Eur J Nucl Med Mol Imaging (2005) 32:581–588

_______________________________________________________________

Succinylated gelatine. An alternative to hydroxyethyl starch for labelling leukocytes with 99mTc-HMPAO

Nuclear Medicine Communications 2005, 26:749–752

_______________________________________________________________

Ten Simple Rules for Getting Published

PLoS Computational Biology. October 2005  Volume 1  Issue 5  e57

_______________________________________________________________

Towards a harmonized radiopharmaceutical regulatory framework in Europe

Q J Nucl Med Mol Imaging 2005; 53:394-401

_______________________________________________________________

A Better Method of Quality Control for 99mTc-Tetrofosmin

J Nucl Med Technol 2004; 32:72–78

_______________________________________________________________

Guidelines for the measurement of glomerular filtration rate using plasma sampling

Nuclear Medicine Communications 2004, 25:759–769

_______________________________________________________________

Alternative quality control for technetium-99m IDA complexes

Applied radiation and isotopes. 2004;61:1151-55

_______________________________________________________________

A Simple and Effective Technique to Reduce Staff Exposure During the Preparation of Radiopharmaceuticals

J Nucl Med Technol 2003; 31:37–40

_______________________________________________________________

Performance of a device to minimise radiation dose to the hands during radioactive syringe calibrations

Eur J Nucl Med Mol Imaging (2003) 30:819-825

_______________________________________________________________

Drug Interactions With Radiopharmaceuticals. Effect on the Labeling of Red Blood Cells with Technetium-99m and on the Bioavailability of Radiopharmaceuticals

Brazilian Archives of Biology and Technology. Vol.45, Special n.: pp. 143-149. September 2002

_______________________________________________________________

Labeling of Mixed Leukocytes with 99mTc-HMPAO Causes Severe Chromosomal Aberrations in Lymphocytes

J Nucl Med 2002; 43:203-206

_______________________________________________________________

Radiochemical purity and particles number determinations of modified 99mTc-macroaggregated albumin

J.Serb.Chem.Soc. 67 (8–9) 573–579 (2002)

_______________________________________________________________

Synthesis of 99mTc-ciprofloxacin by different methods and its biodistribution

Applied Radiation and Isotopes 57 (2002) 193–200

_______________________________________________________________

Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes

J Nucl Med. 2002 Jul;43(7):928-32

_______________________________________________________________

Chemotaxis, Viability, and Labeling Stability of Leukocytes Labeled with 99mTc-Exametazime Stabilized with Methylene Blue

J Nucl Med 2001; 42:505-508

_______________________________________________________________

99mTc-MAG3. Review of pharmacokinetics, clinical application to renal diseases and quantification of renal function

Annals of Nuclear Medicine Vol. 15, No. 3, 179-190, 2001

_______________________________________________________________

A simple and inexpensive preparation of [(51)Cr]-MAA particles

Nucl Med Biol. 2001 Apr;28(3):339-44

_______________________________________________________________

Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection

Eur J Nucl Med (2001) 28:570–574

_______________________________________________________________

Are Leukocytes Labeled with Stabilized 99mTc-HMPAO Becoming Activated During Labeling?

J Nucl Med. Vol. 42, nº 4, April 2001

_______________________________________________________________

Self-radioiodination of iodogen

Applied Radiation and Isotopes 54 (2001) 749-752

_______________________________________________________________

Structural overview of technetium compounds (1993–1999)

Coordination Chemistry Reviews 214 (2001) 43–90

_______________________________________________________________

Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides

Nucl Med Biol. 2001 May;28(4):409-18

_______________________________________________________________

Evaluation of an Alternative Radiochemical Purity Testing Method for Technetium-99m-Sestamibi

J Nucl Med Technol 2000; 28:259–263

_______________________________________________________________

Measurement of plasma volume using 99Tc(m)-labelled DMP-HSA

Nucl Med Commun. 2000 Jun;21(6):539-44

_______________________________________________________________

Performance of a 62Zn-62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM

J Nucl Med. 2000 Feb;41(2):309-14

_______________________________________________________________

Should whole-body red cell mass be measured or calculated

Blood Cells Mol Dis. 2000 Feb;26(1):25-31; discussion 32-6.

_______________________________________________________________

Simplified algorithms for the estimation of 99Tcm-MAG3 clearance

Nucl Med Commun. 2000 Jan;21(1):65-9

_______________________________________________________________

Artefacts in the thin-layer chromatographic analysis of 99Tcm-tetrofosmin injections

Nucl Med Commun. 1999 May;20(5):439-44

_______________________________________________________________

Effect of obesity on red cell mass results

J Nucl Med. 1999 Mar;40(3):422-8

_______________________________________________________________

Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals

Nucl Med Commun. 1999 Jan;20(1):61-5

_______________________________________________________________

Estimating plasma volume from red cell volume

Nucl Med Commun. 1999 Dec;20(12):1165-7

_______________________________________________________________

Labelling of platelets with indium-111 oxine and technetium-99m HMPAO: suggested methods

Eur J Nucl Med. 1999;26(12):1614-1616

_______________________________________________________________

The influence of stereoisomerism on the pharmacokinetics of Tc radiopharmaceuticals

Q J Nucl Med. 1998 Dec;42(4):280-93

_______________________________________________________________

Rapid miniaturized chromatography for technetium-99m-tetrofosmin

J Nucl Med Technol. 1997 Mar;25(1):52-4

_______________________________________________________________

Red cell mass and plasma volume measurement

Nucl Med Commun. 1997 Mar;18(3):189-90

_______________________________________________________________

Clinical Radiopharmacy. Principles and Practices

Seminars in Nuclear Medicine, Vol XXVI, No 2 (April), 1996: pp 77-84

_______________________________________________________________

Measurement of Blood Volume and Red Cell Mass. Re-examination of 51Cr and 125I Methods

Blood Cells Mol Dis. 1996;22(2):169-86

_______________________________________________________________

Measurement of Renal Function with Technetium-99m-MAG3 in Children and Adults

J Nucl Med 1996; 37:588-593

_______________________________________________________________

MIRDOSE. Personal computer software for internal dose assessment in nuclear medicine

J Nucl Med. 1996 Mar;37(3):538-46

_______________________________________________________________

Prevalence of Adverse Reactions in Nuclear Medicine

J Nucl Med 1996; 37:185-192

_______________________________________________________________

Problems associated with the clinical use of radiopharmaceuticals. A proposed classification system and troubleshooting guide

Eur J Nucl Med (1996) 23:997-1002

_______________________________________________________________

Radiopharmaceutical-Related Pitfalls and Artifacts

Semin Nucl Med. 1996 Oct;26(4):208-55

_______________________________________________________________

Report of the Radionuclides in Nephrourology Committee on Renal Clearance

J Nucl Med 1996; 37:1883-1890

_______________________________________________________________

Failure to label red blood cells adequately in daily practice using an in vivo method. Methodological and clinical considerations

Eur J Nucl Med. 1995 Jan;22(1):61-7

_______________________________________________________________

Quality assurance of radiopharmaceuticals

Nucl Med Commun. 1994 Nov;15(11):886-9

_______________________________________________________________

Drug interactions with radiopharmaceuticals

Eur J Nucl Med. 1994;21:348-356

_______________________________________________________________

Radioisotopic Labels for Blood cell Survival Studies: a Review

Nucl Med Biol. 1993 Oct;20(7):809-17

_______________________________________________________________

An assessment of factors which influence the effectiveness of the modified in vivo technetium-99m-erythrocyte labeling technique in clinical use

J Nucl Med. 1992 Dec;33(12):2222-5

_______________________________________________________________

Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects

J Nucl Med. 1992 Apr;33(4):480-4

_______________________________________________________________

The Technetium-99m-DTPA Renal Uptake Plasma Volume Product. A Quantitative Estimation of Glomerular Filtration Rate

J NucI Med 1992;33:1712-1716

_______________________________________________________________

99Tcm-exametazime-labelled leucocytes. Effect of volume and concentration of exametazime on labelling efficiency

Nucl Med Commun. 1991 Aug;12(8):719-23

_______________________________________________________________

Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method

J Nucl Med 1991; 32:1294-1297

_______________________________________________________________

Reference values for red cell survival times

 J Nucl Med. 1991 Dec;32(12):2245-8

_______________________________________________________________

A radiopharmaceuticals schedule for imaging in paediatrics

Eur J Nucl Med (1990) 17:127-129

_______________________________________________________________

Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brain

J Nucl Med. 1990 Jan;31(1):118-22

_______________________________________________________________

Radiopharmaceuticals. State of the art

Eur J Nucl Med. 1990;17(6-8):346-64

_______________________________________________________________

The chemistry of 99mTc-labeled radiopharmaceuticals

Semin Nucl Med. 1990 Jan;20(1):5-27

_______________________________________________________________

Cationic Complexes of Technetium for Myocardial Imaging

 J Nucl Med 30: 1415-1419, 1989

_______________________________________________________________

Estimation of ERPF in adults from plasma clearance of 131I-hippuran using a single injection and one or two blood samples

Int J Rad Appl Instrum B. 1989;16(4):381-3

_______________________________________________________________

Estimation of Technetium-99m-MAG3 Plasma Clearance in Adults from One or Two Blood Samples

J Nucl Med 30:1955-1959, 1989

_______________________________________________________________

Kinetic Analysis of Technetium-99m d,l-HM-PAO Decomposition in Aqueous Media

J Nucl Med 29:1568-1576, 1988

_______________________________________________________________

Recommended Method for Indium-111 Platelet Survival Studies

J Nucl Med 29:564-566,1988

_______________________________________________________________

Technetium-99m HM-PAO stereoisomers. Differences in interaction with glutathione

J Nucl Med. 1988 Dec;29(12):1998-2000

_______________________________________________________________

Single-sample method for the estimation of glomerular filtration rate in children

J Nucl Med. 1987 Mar;28(3):366-71

_______________________________________________________________

Evaluation of mathematic models to assess platelet kinetics

J Nucl Med 27:1192-1201, 1986

_______________________________________________________________

Measurement of splenic function with heat-damaged RBCs: effect of heating conditions: concise communication

 J Nucl Med. 1984 Sep;25(9):965-8

_______________________________________________________________

Recommended Method for Radioisotope Red Cell Survival Studies

British Journal of Haematology, 1980. 45, 659-666

_______________________________________________________________

Recommended methods for measurement of red-cell and plasma volume: International Committee for Standardization in Haematology

J Nucl Med. 1980 Aug;21(8):793-800

_______________________________________________________________

Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals

J Nucl Med. 1977 Dec;18(12):1230-3

_______________________________________________________________

Recommended methods for radioisotope platelet survival studies

Blood. 1977 Dec;50(6):1137-44

_______________________________________________________________

Simultaneous red cell mass and plasma volume determinations using 51Cr tagged red cells and 125I labeled albumin

J Nucl Med. 1965, 6:433-440

____________________________________________________________

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s